Quick Answer
PepGen Inc. reported R&D Expense of $71.04 million for fiscal year 2025.
PepGen Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $71.04M | -7.1% |
| 2024 | $76.48M | +12.3% |
| 2023 | $68.13M | +26.0% |
| 2022 | $54.08M | +184.6% |
| 2021 | $19.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.42M | -24.3% | -27.0% |
| June 30, 2025 | $18.39M | -26.6% | -27.5% |
| March 31, 2025 | $25.38M | +72.3% | +43.2% |
| September 30, 2024 | $17.72M | -13.7% | -29.3% |
| June 30, 2024 | $25.06M | +48.1% | +70.1% |
| March 31, 2024 | $14.73M | +2.6% | -28.3% |
| September 30, 2023 | $20.54M | +28.7% | +21.4% |
| June 30, 2023 | $16.93M | +18.9% | +17.9% |
- PepGen Inc. showed a decrease of -7.1% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, PepGen Inc.’s r&d expense has grown by 273.9% (from $19.00 million to $71.04 million).
- The most recent figure is from PepGen Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: